ANGIOTECH PHARMA (NASDAQ:ANPI)

1.30

+0.01 (0.78%)

ANGIOTECH PHARMA (NASDAQ:ANPI) Delayed :
Previous Close	$1.29	52 Week High	$2.94
Open	$1.29	52 Week Low	$0.10
Day High	$1.31	P/E	N/A
Day Low	$1.28	EPS	$0.00
Volume	130,384
More ANPI Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
BSX	9	ANP	4
KERX	3	MITI	3
MBI	3	ARNA	3
STEC	2	BCSI	2
AGEN	2	LGF	2
REV	2	TMRK	2

View All Entities

Nov 6, 2009 01:29 PM Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
Oct 19, 2009 04:36 PM Angiotech Pharmaceuticals (ANPI) Receives FDA Letter Regarding 510k Submission of Bio-Seal
Sep 30, 2009 03:08 PM Angiotech Pharma (ANPI) CEO Hunter Buys 49.5K Shares
Sep 22, 2009 02:34 PM Angiotech Pharmaceuticals (ANPI) Issues Update on TAXUS Liberte Stent
Sep 2, 2009 03:35 PM Angiotech (ANPI) Announces Boston Scientific (BSX) Reports 2-Yr Data from SYNTAX Trial on Taxus(R) Express(R) Stents

Nov 9, 2009 07:00AM Angiotech Pharmaceuticals, Inc. announces financial results for the third quarter ended September 30, 2009
Oct 23, 2009 09:00AM Angiotech Pharmaceuticals announces commercial launch of the Tan Endoglide(TM) Endothelium Insertion System in the United States at the American Academy of Ophthalmology annual meeting
Oct 19, 2009 04:30PM Angiotech Pharmaceuticals provides update on Bio-Seal(TM) 510(K) submission
Oct 9, 2009 12:35PM Angiotech Pharmaceuticals, Inc. Announces Conference Call and Webcast

Oct 20, 2009 11:36 AM BioMed News Bytes: Angiotech, BioSante, HGSI
Aug 13, 2009 04:22 PM Closing Update for Thursday, August 13: Strong Finish
Aug 11, 2009 04:26 PM Closing Update for Tuesday, August 11: Back-to-Back Losses
Aug 2, 2009 05:06 AM Extreme FDA Trades: 30 Stocks Under 5 Bucks
Jul 6, 2009 05:21 AM Medical Device Trades: 7 Stocks Under 5 Bucks

Nov 9, 2009 05:23PM Form 8-K ANGIOTECH PHARMACEUTICAL For: Nov 09
Nov 9, 2009 03:01PM Form 10-Q ANGIOTECH PHARMACEUTICAL For: Sep 30
Oct 15, 2009 05:27PM Form 8-K ANGIOTECH PHARMACEUTICAL For: Oct 11
Sep 30, 2009 02:56PM Form 4 ANGIOTECH PHARMACEUTICAL For: Sep 29 Filed by: Hunter William L

Ray
on Jan 27, 2009
at 09:09 AM Quill Profit growth accelerating for revolutionary product line. All reports from the field, including the largest catholic health care system in the U.S. and the largest plastic surgery group in the U.S., are totally comitted to the product. Unique product characteristics are reducing operating room time by 40 %. Word is spreading from doctor to doctor and product is gaining wide acceptance. Potential takeover candidate by larger competitors who know the the product line is a threat to their existing business
Article: Angiotech (ANPI) to Consider Initiatives to Reduce Operating Costs
Eduardo Mendez
on Aug 11, 2008
at 08:58 AM How does ANPI avoid bankruptcy? It is worth noting that the losses the company is reporting do NOT include the interest payments on its debt. Hence, its cash burn is far higher than the numbers headline in recent quarterly results announcements.
Article: RBC Cuts Price Target on Angiotech (ANPI) to $4

No comments are currently available.